Oxford, UK – PrecisionLife CEO Dr Steve Gardner will be chairing a discussion at this event, organised by One Nucleus in collaboration with Stevenage Bioscience Catalyst.
The session will feature a panel of experienced entrepreneurs discussing the different ways that AI can be used to aid successful drug discovery and development, what is needed to optimize these various business models and ultimately how can companies mature innovation in this space to create patient impact faster.
For more information please see https://onenucleus.com/civicrm/event/info?reset=1&id=1423